Synonyms:
Status: Phase 3
Entry Type: Antibody
Molecule Category: UNKNOWN
UNII: P256HB60FF

Pharmacology

Action Mechanism of Action Reference
BINDING AGENT Delta-like protein 3 binding agent PubMed Other PubMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Small Cell Lung Carcinoma 3 D055752 ClinicalTrials
Neoplasms 2 D009369 ClinicalTrials
Neoplasms 2 D009369 ClinicalTrials

Cross References

Resources Reference
CAS NUMBER 1613313-09-9
ChEMBL CHEMBL3990011
FDA SRS P256HB60FF
Guide to Pharmacology 10561